Bay Street News

EnWave Reports 2023 Fourth Quarter and Annual 2023 Consolidated Financial Results

VANCOUVER, British Columbia, Dec. 15, 2023 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) reported the Company’s consolidated interim financial results for the fourth quarter and fiscal year ended September 30, 2023.

All values in thousands and denoted in CAD unless otherwise stated.

Consolidated Financial Performance:

($ ‘000s) Three months ended
September 30,
Year ended
September 30,
  2023 2022 Change
%
2023 2022 Change
%
             
Revenues 1,457 2,824 (48)% 11,363 11,048 3%
Direct costs (1,036) (1,725) (40)% (6,930) (5,872) 18%
Gross margin 421 1,099 (62)% 4,433 5,176 (14)%
             
Operating expenses            
General and administration 435 537 (19)% 2,188 2,737 (20)%
Sales and marketing 229 421 (46)% 1,396 2,102 (34)%
Research and development 357 468 (24)% 1,577 1,998 (21)%
  1,021 1,426 (28)% 5,161 6,837 (25)%
             
Net (loss) continuing operations (605) (451) (34)% (1,579) (2,642) 40%
Net (loss) income discontinued operations 770 (1,822) 142% (4,933) (4,285) (15)%
Adjusted EBITDA(1) (324) (27) (1,100)% 379 (681) 156%
Loss per share:            
Basic and diluted – continuous operations $(0.01) $0.00   $(0.01) $(0.02)  
Basic and diluted – discontinued operations $0.01 $(0.02)   $(0.05) $(0.04)  
  $0.00 $(0.02)   $(0.06) $(0.06)  
(1) Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.
   

EnWave’s annual consolidated financial statements and MD&A are available on SEDAR at www.sedar.com and on the Company’s website www.enwave.net

Key Financial Highlights for the Year Ended 2023 (expressed in ‘000s):

Significant Corporate Accomplishments in Q4 2023 and Subsequently:

Non-IFRS Financial Measures:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring and severance charges, government assistance and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated financial statements.

  Three months ended
September 30,
Year ended
September 30
($ ‘000s) 2023 2022 2023 2022
         
Net (loss) income after income tax 165 (2,273) (6,512) (6,927)
Amortization and depreciation 276 329 1,117 1,098
Stock-based compensation 88 212 556 1,132
Foreign exchange (gain) loss (59) (114) 27 (96)
Finance income (53) (40) (185) (144)
Finance expense 29 37 128 118
Non-recurring impairment expense 315
Government assistance (147)
Discontinued operations (770) 1,822 4,933 4,285
Adjusted EBITDA (324) (27) 379 (681)
         

Non-IFRS financial measures should be considered together with other data prepared accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on www.sedar.com.

About EnWave
EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV™) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty royalty-generating partners spanning twenty-six countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net.

EnWave Corporation

Mr. Brent Charleton, CFA
President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net       

Dylan Murray, CFO at +1 (778) 870-0729
E-mail: dmurray@enwave.net

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Bay Street News